AGTR1 is over-expressed in oestrogen receptor positive (ER+) tumours and mutually exclusive with HER2/neu, indicating the possibility that over-expression of these two genes may represent alternative pathways in breast cancer pathogenesis (Ateeq et al., 2009, Rhodes et al., 2009). The gene discussed is ERBB2; the disease is breast carcinoma.